Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem

A. Kuhnke, M. Serke, R. Erbes, H. Lode (Berlin, Germany)

Source: Annual Congress 2004 - Complications of lung cancer or its treatment quality of life - prognosis
Session: Complications of lung cancer or its treatment quality of life - prognosis
Session type: Thematic Poster Session
Number: 566
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kuhnke, M. Serke, R. Erbes, H. Lode (Berlin, Germany). Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem. Eur Respir J 2004; 24: Suppl. 48, 566

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005

Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 77s
Year: 2005

Neutropenia in lung cancer cases after chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 753s
Year: 2006

Chemotherapy induced neutropenia in lung cancer patients: a single centre study
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006

Aggressive skin cancers associated with prolonged voriconazole therapy in 4 lung transplant patients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009

Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Source: Eur Respir J 2001 Jan 01;19(4):743-755
Year: 2002



Role of flexible bronchoscopy in the management of patients with febrile neutropenia and lung infiltrates in a cancer setting hospital
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


The use of piperacillin/tazobactam for treatment of pneumonia in neutropenic patients
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Second-line treatment patients at relapse of disseminated small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001

Evaluation of intrapericardial cisplatin (CIS) administration in cases with recurrent malignant pericardial effusion (MPE) in pts with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 63s
Year: 2003

First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011

Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010


Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia
Source: International Congress 2015 – New insights into IIPs
Year: 2015